机构:[1]Department of Hepatobiliary and Pancreatic Surgery, General Surgery Centre, First Hospital of Jilin University, Changchun, Jilin, China.[2]Hepatobiliary Surgery and Transplant Unit, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy.[3]Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.[4]Liver Cancer Program, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, USA.[5]Department of Surgery, Ohio State University, Wexner Medical Center, Columbus, Ohio, USA.[6]Department of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.[7]Department of Hepatobiliary Surgery, Pu'er People's Hospital, Pu'er, Yunnan, China.[8]Department of General Surgery, First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.[9]Department of General Surgery, Ziyang First People's Hospital, Ziyang, Sichuan, China.[10]Department of Hepatobiliary Surgery, Fuyang People's Hospital, Fuyang, Anhui, China.[11]Department of General Surgery, Cancer Centre, Division of Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.[12]Department of General Surgery, Liuyang People's Hospital, Liuyang, Hunan, China.[13]The Second Department of Hepatobiliary Surgery, Meizhou People's Hospital, Meizhou, Guangdong, China.[14]The First Department of General Surgery, The Fourth Hospital of Harbin, Harbin, Heilongjiang, China.[15]Department of Hepatobiliary Surgery, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.[16]Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Navy Medical University), Shanghai, China.[17]Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
This study was supported by the National Natural Science
Foundation of China (No. 81972726 and No. 82273074 (T.Y.); No.
82241223 and No. U20A20360 (G.L.)), the Dawn Project
Foundation of Shanghai (No. 21SG36 (T.Y.)), the Shanghai Health
Academic Leader Program (No. 2022XD001 (T.Y.)), and the
Shanghai Outstanding Academic Leader Program (No.
23XD1424900 (T.Y.))
第一作者机构:[1]Department of Hepatobiliary and Pancreatic Surgery, General Surgery Centre, First Hospital of Jilin University, Changchun, Jilin, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Hepatobiliary and Pancreatic Surgery, General Surgery Centre, First Hospital of Jilin University, Changchun, Jilin, China.[16]Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Navy Medical University), Shanghai, China.[*1]Department of Hepatobiliary and Pancreatic Surgery, General Surgery Centre, First Hospital of Jilin University, No. 1 Xinmin Street, Changchun, 130021, Jilin, China[*2]Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, No. 225 Changhai Road, Shanghai, 200438, China
推荐引用方式(GB/T 7714):
Fan Zhong-Qi,Serenari Matteo,Lv Xing,et al.Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma[J].BRITISH JOURNAL OF SURGERY.2024,111(3):doi:10.1093/bjs/znae047.
APA:
Fan Zhong-Qi,Serenari Matteo,Lv Xing,Schwartz Myron,Qiu Wei...&Lv Guoyue.(2024).Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma.BRITISH JOURNAL OF SURGERY,111,(3)
MLA:
Fan Zhong-Qi,et al."Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma".BRITISH JOURNAL OF SURGERY 111..3(2024)